Annual CAPEX
$43.00 K
-$88.00 K-67.18%
December 31, 2023
Summary
- As of February 12, 2025, RSLS annual capital expenditures is $43.00 thousand, with the most recent change of -$88.00 thousand (-67.18%) on December 31, 2023.
- During the last 3 years, RSLS annual CAPEX has fallen by -$347.00 thousand (-88.97%).
- RSLS annual CAPEX is now -89.66% below its all-time high of $416.00 thousand, reached on December 31, 2013.
Performance
RSLS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- RSLS quarterly capital expenditures is not available.
Performance
RSLS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- RSLS TTM capital expenditures is not available.
Performance
RSLS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
RSLS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -67.2% | - | - |
| 3 y3 years | -89.0% | - | - |
| 5 y5 years | -12.2% | - | - |
RSLS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.8% | at low | ||||
| 5 y | 5-year | -89.0% | +207.1% | ||||
| alltime | all time | -89.7% | +207.1% |
ReShape Lifesciences CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $43.00 K(-67.2%) | $0.00(0.0%) | $43.00 K(-64.8%) |
| Sep 2023 | - | $0.00(-100.0%) | $122.00 K(-21.3%) |
| Jun 2023 | - | $36.00 K(+414.3%) | $155.00 K(+18.3%) |
| Mar 2023 | - | $7000.00(-91.1%) | $131.00 K(0.0%) |
| Dec 2022 | $131.00 K(-62.8%) | $79.00 K(+139.4%) | $131.00 K(+10.1%) |
| Sep 2022 | - | $33.00 K(+175.0%) | $119.00 K(-32.0%) |
| Jun 2022 | - | $12.00 K(+71.4%) | $175.00 K(-27.1%) |
| Mar 2022 | - | $7000.00(-89.6%) | $240.00 K(-31.8%) |
| Dec 2021 | $352.00 K(-9.7%) | $67.00 K(-24.7%) | $352.00 K(-20.9%) |
| Sep 2021 | - | $89.00 K(+15.6%) | $445.00 K(-11.7%) |
| Jun 2021 | - | $77.00 K(-35.3%) | $504.00 K(-1.0%) |
| Mar 2021 | - | $119.00 K(-25.6%) | $509.00 K(+30.5%) |
| Dec 2020 | $390.00 K(+2685.7%) | $160.00 K(+8.1%) | $390.00 K(+69.6%) |
| Sep 2020 | - | $148.00 K(+80.5%) | $230.00 K(+180.5%) |
| Jun 2020 | - | $82.00 K(+95.2%) | $82.00 K(+67.3%) |
| Dec 2019 | $14.00 K(-71.4%) | - | - |
| Dec 2018 | $49.00 K(-64.3%) | $42.00 K(>+9900.0%) | $49.00 K(+38.0%) |
| Sep 2018 | - | $0.00(-100.0%) | $35.50 K(-74.4%) |
| Jun 2018 | - | $7000.00(-75.4%) | $138.80 K(+1.2%) |
| Dec 2017 | $137.10 K | $28.50 K(-72.4%) | $137.10 K(+23.4%) |
| Sep 2017 | - | $103.30 K(+1849.1%) | $111.10 K(+1324.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $5300.00(+112.0%) | $7800.00(-44.3%) |
| Dec 2016 | $14.00 K(-64.0%) | $2500.00(>+9900.0%) | $14.00 K(+6.1%) |
| Sep 2016 | - | $0.00(0.0%) | $13.20 K(-5.7%) |
| Jun 2016 | - | $0.00(-100.0%) | $14.00 K(-56.0%) |
| Mar 2016 | - | $11.50 K(+576.5%) | $31.80 K(-18.5%) |
| Dec 2015 | $38.90 K(-56.1%) | $1700.00(+112.5%) | $39.00 K(-60.6%) |
| Sep 2015 | - | $800.00(-95.5%) | $98.90 K(-14.7%) |
| Jun 2015 | - | $17.80 K(-4.8%) | $115.90 K(+15.8%) |
| Mar 2015 | - | $18.70 K(-69.6%) | $100.10 K(+12.9%) |
| Dec 2014 | $88.70 K(-78.7%) | $61.60 K(+246.1%) | $88.70 K(+172.1%) |
| Sep 2014 | - | $17.80 K(+790.0%) | $32.60 K(-91.9%) |
| Jun 2014 | - | $2000.00(-72.6%) | $404.30 K(-3.7%) |
| Mar 2014 | - | $7300.00(+32.7%) | $419.70 K(+0.9%) |
| Dec 2013 | $416.00 K(+444.5%) | $5500.00(-98.6%) | $416.00 K(-4.4%) |
| Sep 2013 | - | $389.50 K(+2138.5%) | $435.10 K(+854.2%) |
| Jun 2013 | - | $17.40 K(+383.3%) | $45.60 K(+42.9%) |
| Mar 2013 | - | $3600.00(-85.4%) | $31.90 K(-58.2%) |
| Dec 2012 | $76.40 K | $24.60 K(>+9900.0%) | $76.40 K(+47.5%) |
| Sep 2012 | - | $0.00(-100.0%) | $51.80 K(0.0%) |
| Jun 2012 | - | $3700.00(-92.3%) | $51.80 K(+7.7%) |
| Mar 2012 | - | $48.10 K | $48.10 K |
FAQ
- What is ReShape Lifesciences annual capital expenditures?
- What is the all time high annual CAPEX for ReShape Lifesciences?
- What is ReShape Lifesciences annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for ReShape Lifesciences?
- What is the all time high TTM CAPEX for ReShape Lifesciences?
What is ReShape Lifesciences annual capital expenditures?
The current annual CAPEX of RSLS is $43.00 K
What is the all time high annual CAPEX for ReShape Lifesciences?
ReShape Lifesciences all-time high annual capital expenditures is $416.00 K
What is ReShape Lifesciences annual CAPEX year-on-year change?
Over the past year, RSLS annual capital expenditures has changed by -$88.00 K (-67.18%)
What is the all time high quarterly CAPEX for ReShape Lifesciences?
ReShape Lifesciences all-time high quarterly capital expenditures is $389.50 K
What is the all time high TTM CAPEX for ReShape Lifesciences?
ReShape Lifesciences all-time high TTM capital expenditures is $509.00 K